BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1209229)

  • 41. [2nd revision consensus on blood transfusion. Central Guidance Organization for Peer Review].
    van Aken WG; Dinkelaar RB; Gorgels JP; Knape JT; van Everdingen JJ
    Ned Tijdschr Geneeskd; 1998 Feb; 142(6):298-300. PubMed ID: 9562730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Erythrocyte concentrates, low in buffy coat: production, preservation and evaluation of its quality].
    Strauss D; Seidel B; Meurer W; Markova NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):104-24. PubMed ID: 6157613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Red cell concentrates and other blood products.
    Rajamäki A
    Ann Clin Res; 1981; 13 Suppl 33():21-5. PubMed ID: 7342840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results].
    Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV
    Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates.
    Flesland O; Ip LS; Storlien AS; Spurkland A; Larsen J; Solheim BG
    Transfus Apher Sci; 2004 Dec; 31(3):173-80. PubMed ID: 15556463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bartonella henselae survives after the storage period of red blood cell units: is it transmissible by transfusion?
    Magalhães RF; Pitassi LH; Salvadego M; de Moraes AM; Barjas-Castro ML; Velho PE
    Transfus Med; 2008 Oct; 18(5):287-91. PubMed ID: 18937735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Whole blood should be replaced by its fractions in the majority of its indications].
    Servais M; Brocteur J; André A
    Rev Med Liege; 1975 Jun; 30(11):357-66. PubMed ID: 1224071
    [No Abstract]   [Full Text] [Related]  

  • 48. [Preparation of an erythrocyte concentrate from whole blood in plastic packs for patients with previous febrile reactions to transfusion].
    Gundolf F
    Ugeskr Laeger; 1976 Aug; 138(34):2059-61. PubMed ID: 968957
    [No Abstract]   [Full Text] [Related]  

  • 49. [THE USE OF FRESH BLOOD, STORED WHOLE BLOOD AND OF CONCENTRATED RED BLOOD CELLS. PROBLEMS POSED BY THE PREPARATION OF RED BLOOD CELL CONCENTRATES FOR TRANSFUSION USES].
    KLEINE N; MATTHES M
    Sangre (Barc); 1963; 42():259-64. PubMed ID: 14112674
    [No Abstract]   [Full Text] [Related]  

  • 50. [Erythrocyte concentrates as substitutes of whole blood; changes in transfusion methods in a regional hospital (author's transl)].
    Brütsch M; Frey-Wettstein M; Schwarz H
    Prakt Anaesth; 1978 Dec; 13(6):528-34. PubMed ID: 740635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Full blood preservation or erythrocyte concentrate].
    Seidl S
    Dtsch Med Wochenschr; 1977 Apr; 102(17):669-70. PubMed ID: 852427
    [No Abstract]   [Full Text] [Related]  

  • 52. [Quality control of red blood cell pockets produced at Centre National de Transfusion Sanguine de Lomé].
    Magnang H; Padaro E; Mawussi K; Ouenangou T; Layibo Y; Kuéviakoé MDI; Vovor A
    Pan Afr Med J; 2019; 32():171. PubMed ID: 31303940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inventions and innovations at a district blood transfusion center].
    Morozov IA; Zub PS; Shcherbak GV; Legostaeva EI
    Probl Gematol Pereliv Krovi; 1977 Aug; 22(8):51-2. PubMed ID: 928342
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hematological studies on changes caused by warming of the blood with microwaves].
    Kägi P; Rüegg R; Straub PW; Hossli G
    Infusionsther Klin Ernahr; 1977 Oct; 4(5):285-9. PubMed ID: 562320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood wastage reduction using Lean Sigma methodology.
    Heitmiller ES; Hill RB; Marshall CE; Parsons BJ; Berkow LC; Barrasso CA; Zink EK; Ness PM
    Transfusion; 2010 Sep; 50(9):1887-96. PubMed ID: 20456700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From omics technologies to personalized transfusion medicine.
    D'Alessandro A
    Expert Rev Proteomics; 2019 Mar; 16(3):215-225. PubMed ID: 30654673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the protein content of red cell concentrates on the optimum use of blood.
    Lundsgaard-Hansen P
    Vox Sang; 1979; 37(2):65-72. PubMed ID: 494583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary processing of red cells - adding insult to injury.
    Thomas S
    Transfus Med; 2012 Jun; 22(3):153-4. PubMed ID: 22587582
    [No Abstract]   [Full Text] [Related]  

  • 59. Establishing an equitable group O D- red blood cell inventory in hospitals.
    Newman B
    Transfusion; 2010 Oct; 50(10):2283-4. PubMed ID: 21039582
    [No Abstract]   [Full Text] [Related]  

  • 60. Blood transfusion therapy in the rear hospital during the Yom Kippur War (October 1973).
    Sandler SG; Hermoni D
    Mil Med; 1977 Jan; 142(1):49-53. PubMed ID: 402601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.